Latest news
Charles River Benefits From an Improving Demand Environment Despite No Moat - MorningstarMorningstar · Fri, 07 Aug 2026 05:56:11 GMTNo-Moat Revvity Sees Solid First-Half Performance With Momentum Likely to Continue - MorningstarMorningstar · Tue, 04 Aug 2026 20:32:57 GMTNo-Moat Icon Sees Improving Demand Environment Despite Earnings Pressure - MorningstarMorningstar · Tue, 04 Aug 2026 00:06:39 GMTNo-Moat UCB's Growth Products Fuel Revenue Expansion Amid Declining Sales for Legacy Drugs - MorningstarMorningstar · Fri, 31 Jul 2026 19:01:05 GMTNo-Moat Incyte Faces Jakafi Patent Cliff as Focus Remains on Opzelura and Expanding Portfolio - MorningstarMorningstar · Wed, 29 Jul 2026 23:50:19 GMTYour Product Is No Longer The Moat. Your Distribution Is. - TekediaTekedia · Sun, 26 Jul 2026 17:07:24 GMT